Comparison of liver biochemical abnormality between COVID-19 patients with liver cirrhosis versus COVID-19 alone and liver cirrhosis alone: A STROBE observational study

Coronavirus disease (COVID-19) patients frequently develop liver biochemical abnormality. However, liver biochemical abnormality in COVID-19 patients with liver cirrhosis is under-recognized. Patients hospitalized during COVID-19 pandemic in China (ie, from February to April 2020) were screened. All...

Descripción completa

Detalles Bibliográficos
Autores principales: An, Yang, Ma, Zhuang, Guo, Xiaozhong, Tang, Yufu, Meng, Hao, Yu, Hao, Peng, Chengfei, Chu, Guiyang, Wang, Xinwei, Teng, Yue, Zhang, Quanyu, Zhu, Tianyi, Wang, Bing, Tong, Zhenhua, Zhao, Haitao, Lu, Hui, Qi, Xingshun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133226/
https://www.ncbi.nlm.nih.gov/pubmed/34106589
http://dx.doi.org/10.1097/MD.0000000000025497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133226/
https://www.ncbi.nlm.nih.gov/pubmed/34106589
http://dx.doi.org/10.1097/MD.0000000000025497

Ejemplares similares